- Home
- BBDC vs CRMD Comparison
BBDC vs CRMD Comparison
Compare BBDC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBDC
- CRMD
- Stock Information
- Founded
- BBDC 2006
- CRMD 2006
- Country
- BBDC United States
- CRMD United States
- Employees
- BBDC N/A
- CRMD N/A
- Industry
- BBDC Diversified Financial Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- BBDC Finance
- CRMD Health Care
- Exchange
- BBDC Nasdaq
- CRMD Nasdaq
- Market Cap
- BBDC 1.0B
- CRMD 901.8M
- IPO Year
- BBDC 2007
- CRMD 2010
- Fundamental
- Price
- BBDC $9.91
- CRMD $14.83
- Analyst Decision
- BBDC Buy
- CRMD Strong Buy
- Analyst Count
- BBDC 3
- CRMD 7
- Target Price
- BBDC $9.67
- CRMD $16.83
- AVG Volume (30 Days)
- BBDC 411.1K
- CRMD 3.7M
- Earning Date
- BBDC 08-07-2025
- CRMD 08-07-2025
- Dividend Yield
- BBDC 10.49%
- CRMD N/A
- EPS Growth
- BBDC N/A
- CRMD N/A
- EPS
- BBDC 0.95
- CRMD 0.79
- Revenue
- BBDC $280,314,000.00
- CRMD $121,484,498.00
- Revenue This Year
- BBDC N/A
- CRMD $404.81
- Revenue Next Year
- BBDC N/A
- CRMD $56.11
- P/E Ratio
- BBDC $10.46
- CRMD $18.73
- Revenue Growth
- BBDC N/A
- CRMD 14970.29
- 52 Week Low
- BBDC $7.66
- CRMD $5.31
- 52 Week High
- BBDC $10.85
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- BBDC 69.03
- CRMD 73.44
- Support Level
- BBDC $9.60
- CRMD $13.66
- Resistance Level
- BBDC $9.89
- CRMD $14.44
- Average True Range (ATR)
- BBDC 0.10
- CRMD 0.68
- MACD
- BBDC 0.02
- CRMD 0.24
- Stochastic Oscillator
- BBDC 97.44
- CRMD 97.22
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.